CIK: 1810882 - Address: C/o Intellia Therapeutics, Inc., 40 Erie Street; Suite 130, Cambridge, MA 02139
17 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
1/5/24 16:50
1/3/24
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLebwohl DavidMAOEVP,ChieS-17229.460-6-1054D
1/3/24 17:34
1/1/24
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLebwohl DavidMAOEVP,ChieM.d00.0003660D
1/6/23 17:26
1/4/23
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLebwohl DavidMAOEVP,ChieS-9637.210-3-926D
1/4/23 20:33
1/1/23
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLebwohl DavidMAOEVP,ChieM.d00.00031328D
3/3/22 20:00
1/1/22
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLebwohl DavidMAOEVP,ChieS.d-118112.240-1-425D
3/3/22 20:00
1/1/22
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLebwohl DavidMAOEVP,ChieM.d00.00031525D
11/9/21 18:08
11/5/21
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLebwohl DavidMAOEVP,ChieS.d-319132.720-2-229D
11/9/21 18:08
11/5/21
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLebwohl DavidMAOEVP,ChieM.d3012.6202389D
10/15/21 19:02
10/14/21
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLebwohl DavidMAOEVP,ChieS.d-308128.440-2-229D
10/15/21 19:02
10/14/21
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLebwohl DavidMAOEVP,ChieM.d3012.6202389D
9/27/21 16:15
9/24/21
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLebwohl DavidMAOEVP,ChieM.d10012.6208999%9D
9/23/21 17:48
9/21/21
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLebwohl DavidMAOEVP,ChieS.d-360149.810-2-751D
9/23/21 17:48
9/21/21
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLebwohl DavidMAOEVP,ChieM.d3012.62021D
9/1/21 19:32
8/30/21
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLebwohl DavidMAOEVP,ChieS.d-379158.040-2-751D
9/1/21 19:32
8/30/21
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLebwohl DavidMAOEVP,ChieM.d3012.62021D
8/11/21 16:50
8/9/21
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLebwohl DavidMAOEVP,ChieM.d3012.62021D
8/11/21 16:50
8/9/21
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLebwohl DavidMAOEVP,ChieS.d-394164.050-2-751D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact